Table 2.
Association between NSCLC and different subpopulations of T cells (mean ± SD).
Variables (%) |
Control n = 35 |
Stage IIIa n = 14 |
Stage IIIb n = 17 |
Stage IV n = 52 |
F value | P value |
---|---|---|---|---|---|---|
CD3+ | 71.7 ± 2.5 | 69.8 ± 1.6∗ | 69.7 ± 1.8∗ | 65.7 ± 2.7∗†§ | 46.7 | 0.00 |
CD4+ | 39.4 ± 0.9 | 37.0 ± 1.2∗ | 36.9 ± 0.9∗† | 31.7 ± 3.5∗§ | 74.4 | 0.00 |
CD8+ | 29.2 ± 0.7 | 29.3 ± 0.9 | 29.6 ± .9 | 29.5 ± 1.1 | 0.79 | 0.61 |
CD4+/CD8+ | 1.4 ± 0.1 | 1.3 ± 0.1∗ | 1.3 ± 0.1∗ | 1.1 ± 0.1∗†§ | 106.5 | 0.00 |
NK | 18.1 ± 1.2 | 15.8 ± 0.9∗ | 15.7 ± 0.8∗ | 14.6 ± 1.2∗†§ | 70.4 | 0.00 |
Treg cell | 5.4 ± 0.4 | 7.4 ± 0.5 | 8.0 ± 1.0 | 8.9 ± 1.6 | 63.2 | 0.01 |
∗ P < 0.05, versus control; †P < 0.05, versus stage IIIa; §P < 0.05, versus stage IIIb.